惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

H
Hackread – Cybersecurity News, Data Breaches, AI and More
C
Check Point Blog
Hacker News: Ask HN
Hacker News: Ask HN
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
WordPress大学
WordPress大学
P
Proofpoint News Feed
V
Visual Studio Blog
C
Cyber Attacks, Cyber Crime and Cyber Security
N
Netflix TechBlog - Medium
C
CXSECURITY Database RSS Feed - CXSecurity.com
博客园 - 聂微东
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
博客园 - 叶小钗
Cisco Talos Blog
Cisco Talos Blog
S
Schneier on Security
T
Threat Research - Cisco Blogs
腾讯CDC
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
The Hacker News
The Hacker News
Google DeepMind News
Google DeepMind News
Microsoft Security Blog
Microsoft Security Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
GbyAI
GbyAI
N
News | PayPal Newsroom
L
LINUX DO - 最新话题
酷 壳 – CoolShell
酷 壳 – CoolShell
P
Palo Alto Networks Blog
T
Tenable Blog
S
Secure Thoughts
T
Threatpost
V2EX - 技术
V2EX - 技术
大猫的无限游戏
大猫的无限游戏
Martin Fowler
Martin Fowler
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Vercel News
Vercel News
罗磊的独立博客
P
Privacy & Cybersecurity Law Blog
Engineering at Meta
Engineering at Meta
小众软件
小众软件
Google DeepMind News
Google DeepMind News
N
News and Events Feed by Topic
Y
Y Combinator Blog
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
C
Cybersecurity and Infrastructure Security Agency CISA
P
Proofpoint News Feed
L
Lohrmann on Cybersecurity
P
Privacy International News Feed
H
Heimdal Security Blog
量子位
B
Blog

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
There’s An Ebola Outbreak. Here’s What Could Happen Next, From A Doctor
Jesse Pines · 2026-05-18 · via Forbes - Healthcare
Transmission electron micrograph (TEM) of an Ebola virus virion

A colorized electron microscope image of the Ebola virus. The WHO has declared the Bundibugyo strain — for which no approved vaccine or treatment exists — a global health emergency after cases emerged in the Democratic Republic of Congo and spread to Uganda in May 2026.

getty

The World Health Organization has declared a new Ebola outbreak in the Democratic Republic of Congo a public health emergency of international concern. This is the most serious designation short of a pandemic emergency, which was how COVID-19 was classified.

The announcement came just days after health officials confirmed a deadly, fast-moving strain of Ebola was spreading across one of the world’s most remote and conflict-torn regions. It had already crossed an international border.

The current outbreak, centered in Congo's northeastern Ituri province, has been confirmed as the Bundibugyo strain: a rare and understudied Ebola virus for which no approved vaccine or treatment exists.

As of this writing, at least 88 people have died and more than 336 suspected cases have been recorded across the health zones of Rwampara and Mongwalu, with additional cases confirmed in Bunia, Ituri's provincial capital. More alarming still, the virus has already reached Uganda.

A 59-year-old Congolese man died of confirmed Bundibugyo Ebola in Kampala on May 14 as the first confirmed international spread of this outbreak. Then, on May 16, a second laboratory-confirmed case with no apparent link to the first was reported in Kampala. It was an individual who had traveled from DRC. This raises the alarming possibility that the exposure chain within Uganda is larger than currently known.

This is Congo's 17th Ebola outbreak since the virus was first identified there in 1976. Each one has tested the limits of the global health response. This one may prove difficult to control.

Why This Ebola Outbreak Is More Concerning

Past Congo outbreaks including the catastrophic 2018 to 2020 epidemic that killed nearly 2,300 people were caused by the Zaire strain of Ebola. A vaccine called rVSV-ZEBOV (Ervebo) was developed against the Zaire strain following the catastrophic 2014 to 2016 Ebola outbreak.

The 2018 to 2020 Ebola pandemic used a process called ring vaccination where contacts of confirmed cases were rapidly immunized. This process helped suppress spread, even in an active conflict zone.

The problem is that there is no proven vaccine against the Bundibugyo Ebola strain. The Bundibugyo strain of Ebola causes sudden flu-like symptoms with fever that quickly progress to severe vomiting, diarrhea, and in many cases, bleeding. Ebola is also called Ebola hemorrhagic fever because of the bleeding. The mortality rate for the Bundibugyo strain is estimated to be between 30% and 50%

The Bundibugyo strain was first identified in 2007 in Uganda's Bundibugyo district and caused an outbreak in Congo in 2012. Experimental vaccines have been tested in animal models, but none have completed the clinical trial pathway to approval.

In a fast-moving outbreak with cases already appearing in a major capital city, that gap is the central challenge facing public health officials now.

A further complication: standard rapid diagnostic field tests often miss the Bundibugyo strain. Unlike Zaire, which has well-validated point-of-care tests, Bundibugyo is rare enough that field diagnostics were not designed for it. This means that the confirmed case counts almost certainly understate true disease burden compounding the already-delayed detection timeline.

The Kampala cases also illustrate how quickly cross-border transmission can escape notice. The first Kampala patient traveled to Uganda via public transportation, died in a hospital and his body was then transported back across the border to DRC for burial. Each step was a potential exposure event.

Africa CDC Director Jean Kaseya acknowledged uncertainty about what protective gear healthcare workers had used when treating the patient, noting plainly: “We don’t have manufacturing for PPE.” That admission captures the asymmetry at the heart of this outbreak: the virus moves faster than the infrastructure designed to stop it.

Another factor that makes this outbreak especially concerning is how long it appears to have been spreading before it was identified. The suspected index case was a nurse who died at the Evangelical Medical Centre in Bunia after presenting with classic symptoms.

By the time that case triggered an official response, contact tracers were already facing a weeks-long chain of potential exposures they could not fully reconstruct. This made is significantly harder to find contacts for all the cases.

Detection was further complicated by Ituri's geography and security situation. The province sits more than 1,000 kilometers from Kinshasa, connected by poor roads and crossed by active armed conflict. These conditions slow everything from specimen transport to response team deployment. Médecins Sans Frontières has teams in the area and is mobilizing additional resources, but the operational environment remains extraordinarily difficult.

Some experts have also raised the question whether cuts to global health funding have compromised the early warning infrastructure that might have caught this sooner.

Epidemiologist Jennifer Nuzzo speculated publicly that the delayed detection could reflect the erosion of programs designed to identify exactly these kinds of outbreaks before they reach hundreds of cases.

The historical rarity of Bundibugyo is also itself part of the problem. Dr. Jean-Jacques Muyembe — the Congolese virologist who co-discovered Ebola in 1976 — has noted that all but one of Congo’s previous outbreaks involved the Zaire strain.

The global health community’s deep investment in Zaire countermeasures was rational and life-saving, but it left Bundibugyo comparatively understudied, underdiagnosed, and without a licensed vaccine or therapeutic to deploy when it emerged again.

What the WHO Declaration Means

A public health emergency of international concern, or PHEIC, is the WHO’s highest alert designation outside of a formal pandemic emergency. It triggers coordinated international response mechanisms, unlocks emergency funding, and obligates member nations to heightened surveillance and reporting.

WHO Director-General Tedros Adhanom Ghebreyesus was explicit that this is not a pandemic emergency requiring border closures. WHO advised all nations against restricting trade or travel, noting that such measures are not grounded in science. Such measures tend to push movement toward unmonitored informal crossings, and risk undermining both response logistics and local economies.

But a PHEIC is a signal that the situation has crossed a threshold. The combination of a strain with no approved countermeasures, confirmed spread into a second country, cases in a major urban center and a delayed detection timeline can no longer be treated as a regional concern.

What Comes Next To Contain The Spread Of Ebola

The immediate priorities are containment, contact tracing, and supportive care for confirmed cases. International partners including the WHO, Africa CDC and Médecins Sans Frontières are scaling up on the ground. WHO released $500,000 from its Contingency Fund for Emergencies to support surveillance, contact tracing, laboratory testing and clinical care. This is a meaningful first step, though a modest sum relative to what a multi-country Ebola response in a conflict zone demands.

Experimental vaccine candidates for Bundibugyo exist, and emergency use authorization pathways could potentially accelerate their deployment. Yet, regulatory processes take time, and time is precisely what an Ebola outbreak in a conflict zone with a compromised detection baseline does not have.

For the global health community, this outbreak also arrives at a fraught moment with international health funding is under pressure. The surveillance networks and rapid-response infrastructure built painstakingly after the 2014 West Africa epidemic which killed more than 11,000 people and exposed catastrophic gaps in global preparedness are thinner than before.

There are many reasons to be concerned about this particular Ebola outbreak. The question now is whether the global response: its funding, its speed and its political will, ultimately will be enough to contain the spread.